Non-covalent interactions involving halogenated derivatives of capecitabine and thymidylate synthase: a computational approach

Capecitabine, a fluoropyrimidine prodrug, has been a frequently chosen ligand for the last one and half decades to inhibit thymidylate synthase (TYMS) for treatment of colorectal cancer. TYMS is a key enzyme for de novo synthesis of deoxythymidine monophosphate and subsequent synthesis of DNA. Recen...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Adhip, Hoque, Mohammad Mazharol, Khan, Mohammad A. K., Sarwar, Mohammed G., Halim, Mohammad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764604/
https://www.ncbi.nlm.nih.gov/pubmed/27026843
http://dx.doi.org/10.1186/s40064-016-1844-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764604/
https://www.ncbi.nlm.nih.gov/pubmed/27026843
http://dx.doi.org/10.1186/s40064-016-1844-y

Ejemplares similares